ebomi
Colour theme
Sign in
Insider · CIK 0001374150

Domain Parters VII L P

CIK 0001374150 Name as filed on the most recent filing

Filed as Domain Parters VII L P (50)

79 transaction lines · from 50 filings · filed 2008-12-11 to 2019-08-08 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

21 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2019-08-06 Obalon Therapeutics Inc
OBLN 		P, Open-market purchase 250,000 acquired 4.00 1,000,000.00 Form 4, filing 0000904454-19-000600
2018-08-23 Obalon Therapeutics Inc
OBLN 		P, Open-market purchase 1,648,359 acquired 1.82 3,000,013.38 Form 4, filing 0000904454-18-000526
2016-05-26 Evoke Pharma Inc
EVOK 		S, Open-market sale 344,120 disposed 4.70 1,617,364.00 Form 4, filing 0000904454-16-001235
2016-04-27 Evoke Pharma Inc
EVOK 		S, Open-market sale 3,603 disposed 5.02 18,087.06 Form 4, filing 0000904454-16-001187
2016-04-25 Evoke Pharma Inc
EVOK 		S, Open-market sale 1,492 disposed 5.20 7,758.40 Form 4, filing 0000904454-16-001187
2016-04-20 Evoke Pharma Inc
EVOK 		S, Open-market sale 4,424 disposed 5.29 23,402.96 Form 4, filing 0000904454-16-001170
2016-04-19 Evoke Pharma Inc
EVOK 		S, Open-market sale 37,054 disposed 5.36 198,609.44 Form 4, filing 0000904454-16-001170
2016-04-11 Evoke Pharma Inc
EVOK 		S, Open-market sale 4,348 disposed 5.22 22,696.56 Form 4, filing 0000904454-16-001164
2016-04-08 Evoke Pharma Inc
EVOK 		S, Open-market sale 14,554 disposed 5.35 77,863.90 Form 4, filing 0000904454-16-001154
2016-04-07 Evoke Pharma Inc
EVOK 		S, Open-market sale 27,781 disposed 5.26 146,128.06 Form 4, filing 0000904454-16-001154
2016-04-06 Evoke Pharma Inc
EVOK 		S, Open-market sale 8,669 disposed 5.22 45,252.18 Form 4, filing 0000904454-16-001154
2015-08-18 Evoke Pharma Inc
EVOK 		S, Open-market sale 11,836 disposed 7.02 83,088.72 Form 4, filing 0000904454-15-000536
2015-05-04 Regado Biosciences Inc
TBRA 		P, Open-market purchase 277,777 acquired 10.62 2,949,991.74 Form 4, filing 0000904454-15-000262
2015-04-16 Evoke Pharma Inc
EVOK 		S, Open-market sale 32,411 disposed 7.07 229,145.77 Form 4, filing 0000904454-15-000246
2015-04-15 Evoke Pharma Inc
EVOK 		S, Open-market sale 7,920 disposed 7.58 60,033.60 Form 4, filing 0000904454-15-000246
2015-04-14 Evoke Pharma Inc
EVOK 		S, Open-market sale 9,832 disposed 7.78 76,492.96 Form 4, filing 0000904454-15-000246
2014-11-25 Neothetics, Inc.
NEOT 		P, Open-market purchase 70,000 acquired 14.00 980,000.00 Form 4, filing 0000904454-14-000789
2014-11-25 Neothetics, Inc.
NEOT 		P, Open-market purchase 70,000 acquired 14.00 980,000.00 Form 4, filing 0000904454-14-000771
2014-10-21 Esperion Therapeutics, Inc.
ESPR 		P, Open-market purchase 500,000 acquired 20.00 10,000,000.00 Form 4, filing 0000904454-14-000723
2013-07-01 Esperion Therapeutics, Inc.
ESPR 		P, Open-market purchase 280,923 acquired 14.00 3,932,922.00 Form 4, filing 0000904454-13-000768
2013-06-04 Clovis Oncology, Inc.
CLVS 		S, Open-market sale 159,192 disposed 64.58 10,280,619.36 Form 4, filing 0000904454-13-000661
2013-04-15 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 23,210 disposed 6.62 153,650.20 Form 4, filing 0000904454-13-000494
2013-04-10 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 1,567 disposed 6.72 10,530.24 Form 4, filing 0000904454-13-000490
2013-04-09 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 11,386 disposed 6.71 76,400.06 Form 4, filing 0000904454-13-000490
2013-04-08 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 12,217 disposed 6.52 79,654.84 Form 4, filing 0000904454-13-000490
2013-03-21 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 4,374 disposed 5.35 23,400.90 Form 4, filing 0000904454-13-000473
2013-03-20 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 5,510 disposed 5.22 28,762.20 Form 4, filing 0000904454-13-000455
2013-03-19 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 7,925 disposed 5.19 41,130.75 Form 4, filing 0000904454-13-000455
2013-03-18 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 8,020 disposed 5.16 41,383.20 Form 4, filing 0000904454-13-000445
2013-03-15 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 9,636 disposed 5.28 50,878.08 Form 4, filing 0000904454-13-000445
2013-03-14 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 5,020 disposed 5.36 26,907.20 Form 4, filing 0000904454-13-000435
2013-03-13 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 7,733 disposed 5.40 41,758.20 Form 4, filing 0000904454-13-000435
2013-03-12 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 6,346 disposed 5.38 34,141.48 Form 4, filing 0000904454-13-000427
2013-03-11 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 4,118 disposed 5.34 21,990.12 Form 4, filing 0000904454-13-000427
2013-03-08 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 5,154 disposed 5.32 27,419.28 Form 4, filing 0000904454-13-000399
2013-03-07 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 12,701 disposed 5.22 66,299.22 Form 4, filing 0000904454-13-000399
2013-03-06 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 3,839 disposed 5.06 19,425.34 Form 4, filing 0000904454-13-000395
2013-03-06 Clovis Oncology, Inc.
CLVS 		S, Open-market sale 98,349 disposed 24.51 2,410,533.99 Form 4, filing 0000904454-13-000388
2013-03-05 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 4,039 disposed 5.01 20,235.39 Form 4, filing 0000904454-13-000395
2013-03-05 Clovis Oncology, Inc.
CLVS 		S, Open-market sale 126,868 disposed 24.69 3,132,370.92 Form 4, filing 0000904454-13-000388
2013-03-04 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 5,145 disposed 5.01 25,776.45 Form 4, filing 0000904454-13-000376
2013-03-04 Clovis Oncology, Inc.
CLVS 		S, Open-market sale 24,783 disposed 24.44 605,696.52 Form 4, filing 0000904454-13-000388
2013-03-01 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 7,635 disposed 5.01 38,251.35 Form 4, filing 0000904454-13-000376
2013-02-20 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 1,998 disposed 5.01 10,009.98 Form 4, filing 0000904454-13-000315
2013-02-19 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 10,076 disposed 5.02 50,581.52 Form 4, filing 0000904454-13-000311
2013-02-15 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 2,967 disposed 5.00 14,835.00 Form 4, filing 0000904454-13-000311
2013-02-14 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 2,951 disposed 5.01 14,784.51 Form 4, filing 0000904454-13-000295
2013-02-13 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 5,763 disposed 5.00 28,815.00 Form 4, filing 0000904454-13-000295
2013-02-01 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 9,769 disposed 4.85 47,379.65 Form 4, filing 0000904454-13-000159
2013-01-31 Cadence Pharmaceuticals Inc
CADX 		S, Open-market sale 18,537 disposed 4.71 87,309.27 Form 4, filing 0000904454-13-000152

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 21
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. DOMAIN PARTERS VII L P, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001374150

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.